AN2 Therapeutics Enters Open Market Sale Agreement With Jefferies Dated April 9, 2026; Co. May Offer And Sell Common Stock Up To $80M Through Jefferies

Benzinga Newsdesk www.benzinga.com Neutral 87.0%